Table 1 Subject Characteristics

Age (years, range given)*

27 (20-35)

64 (58-70)

Duration of disease

17 (6-30)

37 (4-65)

FEV₁ (L)*

3.35 (+/- 0.81)

2.24(+/- 0.28)

FEV₁ % Predicted

86 (+/- 14.7)

81 (+/- 16.46)

FVC (L)*

4.28 (3.99-5.02)

3.24 (+/- 0.71)

FVC % Predicted

100 (+/- 12.15)

89 (+/- 12.62)

WBC (10⁶cells/mL)

5.55 (4.75-6.85)

5.6 (5.13-6)

Absolute Eosinophil Count (cells/mL)

204 (+/- 127.75)

114 (+/- 82.95)

Positive Allergy Testing⁺

11/12

6/6

Inhaled Corticosteroid Use

6/12

4/6